Effect of a dopamine receptor blockader (domperidone) on serum TSH and growth hormone levels in patients with thyroid diseases
Földes, J.; Bános, C.; Lakatos, P.; Takó, J.
Orvosi Hetilap 125(51): 3095-3101
1984
ISSN/ISBN: 0030-6002 PMID: 6514350 Document Number: 221772
Document emailed within 1 workday
Related Documents
Ferrari, C.; Romussi, M.; Benco, R.; Rampini, P.; Mailland, F. 1983: Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions Acta Endocrinologica 103(1): 1-6Szmit-Domagalska, J.; Petriczko, E.żb.; Drozdzynska, M.; Adler, G.; Horodnicka-Jozwa, A.; Ciechanowicz, A.; Walczak, M.ła. 2016: The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland Neuro Endocrinology Letters 37(4): 282-288
Van den Berghe, G.; de Zegher, F.; Vlasselaers, D.; Schetz, M.; Verwaest, C.; Ferdinande, P.; Lauwers, P. 1996: Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations Critical Care Medicine 24(4): 590-595
Mehta, M.N.; Patel, M.C.; Joseph, L.J.; Velumani, A.; Desai, K.B. 1988: Serum thyroid hormone levels in patients with liver damage: evidence of multiple abnormalities in presence of euthyroidism Journal of the Association of Physicians of India 36(11): 637-639
Zur Mühlen A von; Hesch, R.D.; Emrich, D.; Creutzfeldt, W. 1970: Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis Deutsche Medizinische Wochenschrift 95(52): 2623-2624
Triantafillidis, J.K.; Merikas, E.; Govosdis, V.; Konstandellou, E.; Cheracakis, P.; Barbatzas, C.; Tzourmakliotis, D.; Peros, G. 2003: Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer Hepato-Gastroenterology 50(Suppl 2): Cclvi
Heinen, E.; Herrmann, J.; Lippe, J.; Dudek, M.; Krüskemper, H.L. 1983: Effect of dopamine and dobutamine on thyroid hormone concentration Die Medizinische Welt 34(24): 696-699
Bános, C.; Takó, J.; Györgyi, S. 1978: Relationship between thyroid hormone serum concentration and normal thyroxine values in thyroid diseases Orvosi Hetilap 119(8): 445-449
Pols, H.A.; De Jong, M.J.; Juttmann, J.R.; Lockefeer, J.H. 1983: Failure of H2-receptor antagonists to affect serum calcium and immunoreactive parathyroid hormone levels in normal subjects and patients with primary hyperparathyroidism Netherlands Journal of Medicine 26(6): 149-152
Smyk, J.; Smyk, J.; Smyk, I. 1987: Serum insulin, growth hormone and gastrin levels in children with growth and body weight disorders Pediatria Polska 62(7): 476-484
Matyja, V.; Kos-Kudla, B.; Foltyn, W.; Strzelczyk, J.; Latos, W.; Marek, B.; Kajdaniuk, D.; Karpe, J.; Ostrowska, Z.; Sieron-Stoltny, K.; Sieron, A. 2006: Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels Neuro Endocrinology Letters 27(5): 639-643
Sunthornthepvarakul, T.; Jaruratanasirikul, S.; Likitmaskul, S.; Angsusingha, K.; Ngowngarmratana, S. 2000: An identical neo-mutation in the thyroid hormone receptor beta gene (A317T) in 2 unrelated Thai families with resistance to thyroid hormone Journal of the Medical Association of Thailand 83(2): 139-145
Poyrazoğlu, S.ük.; Tütüncüler, F.; Baş, F.; Darendeliler, F. 2008: Resistance to thyroid hormone in a Turkish child with A317T mutation in the thyroid hormone receptor-beta gene Turkish Journal of Pediatrics 50(6): 577-580
Giusti, M.; Marini, G.; Sessarego, P.; Peluffo, F.; Valenti, S.; Caratti, C.; Giordano, G. 1991: Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone Recenti Progressi in Medicina 82(12): 665-668
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Schuurkes, J.A.; Van Nueten, J.M. 1981: Effects of dopamine and its antagonist domperidone cannot be explained by an effect on alpha 1-adrenergic receptors Archives Internationales de Pharmacodynamie et de Therapie 250(2): 324-327
Raber, W.; Vukovich, T.; Vierhapper, H. 1999: Serum uric acid concentration and thyroid-stimulating-hormone (TSH): results of screening for hyperuricaemia in 2359 consecutive patients with various degrees of thyroid dysfunction Wiener Klinische Wochenschrift 111(8): 326-328
Chang, C.C.; Chen, F.W.; Hsieh, H.C. 1989: Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas Journal of the Formosan Medical Association 88(5): 443-449
Li, G.; Zeng, M. 1990: Relation of serum growth hormone and estradiol levels and osteoporosis in postmenopausal women Zhonghua Yi Xue Za Zhi 70(1): 16-19; 2
Meller, H.; Halawa, B. 1979: Serum levels of thyrotropin, thyroxine, triiodothyronine, growth hormone and insulin in viral hepatitis Polski Tygodnik Lekarski 34(44): 1693-1696